USPTO serial 79391120
EASYSCREEN
Reviewed by CopyMark Law Group
Status 645Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- ALLEN, BIANCA LEIGH
- Law office
- TMO LAW OFFICE 123
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with EASYSCREEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Charles K. Crane
Charles K. Crane Knobbe, Martens, Olson & Bear, LLP2040 Main Street, 14th FloorIrvine, CA 92614United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents, solvents in the nature of chemical reagents and solvents for use in molecular biology, enzymes and assays for scientific use; chemicals, chemical solutions and preparations, namely, liquids, powders and gels for scientific and environmental research; kits for scientific research, namely kits containing nucleic acid molecules and chemical reagents; molecular detection reagents and preparations for microorganism detection for scientific research purposes; substances for analytical and biochemical science, genetic identification, chemical diagnostics, forensic analysis, DNA (deoxyribonucleic acid) testing, and analytical molecular biology, other than for medical or veterinary purposes; chemical and biochemical reagents and preparations for use in molecular biology for scientific research | ACTIVE | — |
| 005 | Chemical and biochemical reagents for medical use and biomedical use and chemical and biochemical preparations for medical purposes, namely, for disease and microorganism identification, all for use in molecular biology; Kits comprised of chemical reagent mixtures containing chemical reagents for medical, clinical, medical laboratory and veterinary use; Assay kits comprised of buffers, enzymes, chemical reagents and solvents and microbiological diagnostic assays for medical diagnostic use for disease and microorganism detection; pharmaceutical, medical and veterinary preparations for the identification and detection of diseases and microorganisms; chemical reagents for the identification of microorganisms, in particular, bacteria, protozoa, virus and fungi for medical, clinical or veterinary use; chemical test reagents for medical purposes; diagnostic reagents for medical laboratory use; nucleic acid amplification reagents for medical use; chemical reagents for analytical purposes for medical purposes; universal chemical reagents for automated test systems for medical purposes; diagnostic kits for medical purposes containing chemicals, biochemicals and other reagents for the detection of microorganisms, in particular bacteria, protozoa, virus and fungi | ACTIVE | — |
| 009 | Scientific equipment, apparatus and instruments, namely, tubes, collection containers, vials, and vessels containing chemical reagents and enzymes as part of a kit for scientific, pharmaceutical and medical research purposes; laboratory experimental machines and apparatus, namely, machines and apparatus for use in connection with nucleic acid sequence amplification and the amplification of other genetic material; laboratory apparatus and instruments, namely, instruments and apparatus for use in connection with nucleic acid sequence amplification and the amplification of other genetic material; DNA (deoxyribonucleic acid) testing apparatus which carry or hold DNA (deoxyribonucleic acid) samples, namely, transportable biological specimen sample kits and containers for use in detecting, screening and sequencing such samples for medical and diagnostic research purposes; gene sequencing products being laboratory apparatus, namely nucleic acid sequencers for scientific purposes, laboratory devices for detecting genetic sequences, and apparatus for use in connection with nucleic acid sequence amplification and the amplification of other genetic material; analytical and diagnostic kits containing scientific apparatus and equipment, namely, equipment and apparatus for use in connection with nucleic acid sequence amplification and the amplification of other genetic material for laboratory or research use | ACTIVE | — |
| 010 | Medical and veterinary apparatus and instruments, namely, instruments and apparatus for use in connection with nucleic acid sequence amplification and the amplification of other genetic material; analytical and diagnostic kits comprising medical apparatus and instruments for microorganism and disease detection and for use in connection with nucleic acid sequence amplification and the amplification of other genetic material, and tubes, collection containers, vials, and vessels filled with culture media, enzymes, culture bottles and reagents as part of medical apparatus and instruments; analytical and diagnostic kits containing tubes filled with chemical reagents and enzymes for use in connection with nucleic acid sequence amplification and the amplification of other genetic material to detect disease and microorganisms; medical devices being in vitro diagnostic testing collection and transport kits comprising apparatus and instruments for disease and microorganism detection and for use in connection with nucleic acid sequence amplification and the amplification of other genetic material, and tubes, collection containers, vials, and vessels filled with culture media, enzymes, culture bottles and chemical reagents and devices for clinical specimens, namely disposable containers and bags for transmitting medical specimens; none of the aforesaid being fluid separation apparatus for separation of liquid from materials for medical use | ACTIVE | — |
| 042 | Scientific and medical research and consultancy and industrial research and consultancy in the field of microbiological and genomic research and disease detection; medical research laboratory services; analysis of tissues for medical research purposes; scientific and technical analysis, namely, the amplification of nucleic acids and other genetic material in particular for the identification of microorganisms; design and development of medical apparatus and testing kits and reagents for medical and clinical use; chemical and biochemical research; chemical and biochemical analysis; analysis of tissues, in particular, blood tissues and specimens, for medical research; consultancy and advisory services in relation to the aforesaid services | ACTIVE | — |
| 044 | Medical services; medical analysis services relating to the identification of microorganisms and disease and for treatment purposes; analysis of tissues, in particular, blood tissues and specimens, for medical treatment purposes; medical diagnostic services, in particular, medical testing and analysis relating to the identification of microorganisms and disease and for treatment purposes; consultancy and advisory services in relation to the aforesaid services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Genetic Signatures Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named EASYSCREEN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 13, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 13, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 13, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 10, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 15, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 15, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 15, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 22, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Aug 8, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 6, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 6, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jul 15, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 15, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 25, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 24, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 23, 2025 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Apr 19, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 18, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 18, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 17, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 17, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 24, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 7, 2024 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |